tiprankstipranks
SRV Group Plc (GB:0JBJ)
LSE:0JBJ

SRV Group Plc (0JBJ) Income Statement

0 Followers

SRV Group Plc Income Statement

Last quarter (Q4 2022), SRV Group Plc's total revenue was €181.18M, a decrease of -46.12% from the same quarter last year. In Q4, SRV Group Plc's net income was €-10.88M. See SRV Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
€ 770.08M€ 137.80M€ 144.50M€ 975.53M€ 1.06B€ 959.67M
Cost of Revenue
€ 688.80M-€ 62.60M€ 869.00M€ 977.03M€ 884.84M
Gross Profit
€ 81.27M€ 137.80M€ 81.90M€ 106.53M€ 83.92M€ 74.83M
Operating Expense
€ 91.65M€ 113.90M€ 58.60M€ 87.01M€ 95.17M€ 96.15M
Operating Income
€ -10.37M€ 23.90M€ 23.30M€ 19.52M€ -11.26M€ -21.32M
Net Non Operating Interest Income Expense
€ -54.88M€ -1.60M€ 2.30M€ -19.59M€ -20.73M€ -13.44M
Other Income Expense
-€ 100.00K----
Pretax Income
€ -78.98M€ 22.20M€ 20.10M€ -27.96M€ -122.35M€ -37.27M
Tax Provision
€ 6.48M€ 4.90M€ 700.00K€ -2.85M€ -18.74M€ -6.06M
Earnings From Equity Interest Net Of Tax
-€ -100.00K----
Net Income Common Stockholders
€ -87.58M€ 17.50M€ 19.40M€ -26.54M€ -110.02M€ -33.27M
Basic EPS
-€ 0.38€ 0.43---
Diluted EPS
-€ 0.43€ 0.41---
Basic Average Shares
-€ 45.60M€ 45.50M---
Diluted Average Shares
-€ 47.80M€ 47.30M---
Dividend Per Share
--€ 0.10---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---€ 665.00K€ 889.00K€ 2.99M
Total Expenses
€ 780.45M€ 113.90M€ -121.20M€ 956.01M€ 1.07B€ 980.99M
Net Income From Continuing And Discontinued Operation
€ -85.66M€ 17.50M€ 19.40M€ -22.81M€ -104.36M€ -30.12M
Normalized Income
€ -67.39M€ 17.98M€ 17.08M€ -16.43M€ -21.33M€ -41.46M
Interest Expense
€ 9.88M--€ 19.07M€ 19.60M€ 13.76M
EBIT
€ -69.50M€ 23.80M€ 22.40M€ -8.89M€ -102.75M€ -23.52M
EBITDA
€ -64.36M€ 28.60M€ 22.40M€ -1.50M€ -94.05M€ -19.88M
Currency in EUR

SRV Group Plc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis